Summary: In a small trial in patients having total thyroidectomy for benign disease, two weeks of preoperative calcium and magnesium produced numerically lower postoperative hypocalcaemia and earlier quality-of-life recovery in Graves’ patients, but the differences were not statistically significant.
PICO Summary
| Element | Detail |
|---|---|
| Population | 62 patients undergoing total thyroidectomy for benign disease (nodular goitre or Graves’ disease); randomised trial, Germany. |
| Intervention | Preoperative calcium carbonate 500 mg three times daily plus magnesium carbonate 300 mg once daily for 2 weeks (n=31). |
| Comparison | No preoperative supplementation (n=31). |
| Outcome | Quality of life improved postoperatively in both groups, with earlier improvement among Graves’ patients in the supplemented group. Postoperative hypocalcaemia occurred in 19.4% (intervention) versus 25% (control), and hypoparathyroidism in 16% versus 23%; these differences were not statistically significant. Vitamin D deficiency was common (66.7%) but did not predict hypocalcaemia. |
Pre-op calcium + magnesium before thyroidectomy
RCT · total thyroidectomy · benign disease
Preoperative calcium and magnesium gave numerically lower postoperative hypocalcaemia and earlier recovery in Graves' patients, but with only 62 patients no difference reached statistical significance.
Expert Commentary
This is a thoughtful prehabilitation trial with a sound rationale, since magnesium is required for both parathyroid hormone secretion and its peripheral action, so correcting it alongside building calcium stores could in principle buffer the parathyroid stunning that follows thyroid surgery. The results should be read honestly, and the post does this well: the lower rates of hypocalcaemia and hypoparathyroidism are encouraging numerical trends, but they did not reach statistical significance, and with only 62 patients the study was underpowered to confirm a true effect. Two secondary observations are interesting, an earlier quality-of-life recovery specifically in Graves’ patients, and the finding that baseline vitamin D deficiency, though present in two-thirds, did not predict postoperative hypocalcaemia, which gently challenges a common assumption. The unblinded design also leaves quality-of-life outcomes open to expectation effects, and the combined intervention cannot separate calcium from magnesium. Can I use this with my patients? As a low-risk option rather than a proven one. Given the safety, low cost, and biological plausibility, brief preoperative calcium and magnesium is reasonable, particularly before thyroidectomy for Graves’ disease, while I would not promise it prevents hypocalcaemia and would maintain standard postoperative calcium monitoring and treatment.
References
Tabriz N, Fried D, Uslar V, Weyhe D. Impact of preoperative calcium and magnesium supplementation on quality of life and hypocalcemia post-thyroidectomy. Endocrinol Diabetes Metab. 2026;9(1):e70129. doi:10.1002/edm2.70129